All clinical trial Articles
-
612Key IssuesShanghai Hospital is All About Protecting Children’s Eyes from Myopia
May 28, 2024 By John Sailer, Editor-in-Chief, Review of Myopia Management As seen through the eyes of the children treated at the Shanghai...
-
764Latest Myopia NewsDopavision’s Clinical Trial Shows Efficacy of MyopiaX-1 Treatment
May 28, 2024 BERLIN, Germany — Dopavision has announced early findings from its clinical trial for MyopiaX-1. The six-month outcomes of the...
-
487Products & ServicesDr. Björn Drobe Discusses Four-Year Results of Essilor Stellest Lenses
sponsored content February 1, 2024 Review of Myopia Management’s Editor-in-Chief John Sailer recently interviewed Dr. Björn Drobe, the Director of R&D Vision Science...
-
847Latest Myopia NewsAmy Chow, FAAO, FBCLA, Shares CooperVision’s Myopia Management Efforts at THE Myopia Meeting Toronto
February 1, 2024 TORONTO – At THE Myopia Meeting held here on Sunday, December 3, 2023, Amy Chow, FAAO, FBCLA, Senior Manager...
-
552Latest Myopia NewsVyluma Releases Four-Year Results From Phase III of CHAMP Study
October 11, 2023 BRIDGEWATER, N.J. — Vyluma has released the results from the second stage of Phase III of its CHAMP (Childhood...
-
670Latest Myopia News
Dopavision Completes Enrollment for MyopiaX-1 Trial
September 26, 2023 BERLIN, Germany — Dopavision has successfully completed enrollment for its MyopiaX-1 clinical trial. MyopiaX-1 is a randomized, active-controlled trial...
-
866Latest Myopia NewsSightGlass Presents Four-Year Results of CYPRESS Trial at CCOS
September 5, 2023 CHANGSHA, China — At the Congress of the Chinese Ophthalmological Society (CCOS) in Changsha, SightGlass Vision shared the four-year results...
-
971Latest Myopia NewsJason Shen, PhD, FAAO, Shares the Latest on Essilor Stellest Lenses at THE Myopia Meeting
August 15, 2023 VANCOUVER — At THE Myopia Meeting held here June 11, 2023, Jason Shen, PhD, FAAO, presented the clinical review...
-
1.1KLatest Myopia NewsDopavision Announces All MyopiaX-1 Clinical Trial Sites are Active
June 28, 2023 BERLIN, Germany — Dopavision’s MyopiaX-1 clinical trial centers are now all active, screening and enrolling participants across Germany, Spain,...
-
1.3KLatest Myopia NewsVyluma Checks Off Last Patient Visit for NVK002 Clinical Trial
September 1, 2022 BRIDGEWATER, N.J. — Vyluma has checked off an important step in its Phase III CHAMP (Childhood Atropine for Myopia...
-
1.1KLatest Myopia NewsVTI’s Six-Year Clinical Trial Data Published in Clinical Ophthalmology
July 8, 2022 ATLANTA — Findings from Visioneering Technologies Inc.’s (VTI) six-year myopia management clinical trial were published in the Clinical Ophthalmology journal. The study...
-
2.0KLatest Myopia NewsVTI Begins International Myopia Control Clinical Trial of NaturalVue Lenses
January 24, 2022 ATLANTA — Visioneering Technologies Inc. announced that it has begun its international clinical trial that is designed to test...
-
3.6KLatest Myopia NewsCooperVision Announces Seven-Year Results from MiSight Clinical Trial at AAO 2021
November 2, 2021 SAN RAMON, Calif. — At the 2021 American Academy of Optometry Meeting in Boston, CooperVision announced the results from...